A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension

NCT01256411 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

341

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: LCZ696
DRUG: Amlodipine
DRUG: Hydrochlorothiazide (HCTZ)

Sponsor

Novartis Pharmaceuticals